procyclidine hydrochloride
CLINICAL USE
Control of extrapyramidal symptoms Acute dystonias
DOSE IN NORMAL RENAL FUNCTION
Oral: 2.5–10 mg 3 times a day; maximum 60 mg dailyAcute dystonias: IM/IV: 5–10 mg
PHARMACOKINETICS
Molecular weight                           :323.9 %Protein binding                           :No data %Excreted unchanged in urine     : <5 Volume of distribution (L/kg)       :1half-life – normal/ESRD (hrs)      :12/– DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unknown dialysability. Dose as in normal renal function HD                     :Not dialysed. Dose as in normal renal function HDF/high flux   :Unknown dialysability. Dose as in normal renal functionCAV/VVHD      :Unknown dialysability. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsNone known ADMINISTRATION
Reconstition
– Route
IV, IM, oral Rate of Administration
Bolus over 3–5 minutes Comments
–
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home